|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/19 | |
| A61K 31/573 | |||
| A61P 31/02 |
| (11) | Number of the document | 2688572 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12759898.5 |
| Date of filing the European patent application | 2012-03-20 | |
| (97) | Date of publication of the European application | 2014-01-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2012/050306 |
| Date | 2012-03-20 |
| (87) | Number | WO 2012/128709 |
| Date | 2012-09-27 |
| (30) | Number | Date | Country code |
| 201161454751 P | 2011-03-21 | US | |
| 1151196 | 2011-12-15 | SE |
| (72) |
DROTT, Kristina, SE
RELANDER, Thomas, SE
|
| (73) |
Valcuria AB,
Scheelevägen 2, 223 81 Lund,
SE
|
| (54) | A PHARMACEUTICAL COMPOSITION COMPRISING A HDAC INHIBITOR AND A STEROID AND THE USE THEREOF. |
| A PHARMACEUTICAL COMPOSITION COMPRISING A HDAC INHIBITOR AND A STEROID AND THE USE THEREOF. |